Advertisement

Search Results for "Rosacea Isotretinoin Erythema"

06:00 EDT 21st May 2013 | BioPortfolio

Original Source: Rosacea Treatment with Intermediate-dose Isotretinoin: Follow-up with Erythema and Sebum Measurements.

Isotretinoin is one of the therapeutic options for rosacea. However, the response of erythema to treatment with isotretinoin is usually slow and incomplete with common (0.5-1 mg/kg/day) or low (10 mg/day) doses. This study investigated the efficacy of, and relapse on, 20 mg/day isotretinoin treatment in rosacea, with the aid of instrumental measurement of facial erythema and sebum levels. A 20 mg/day dose of isotretinoin was given for 4 months, and then the dose was tapered off within the following 6 months...

Matching Channels

Matching News

Treatment For Rosacea | How “Live Rosacea Free” Helps People Get Rid Of Rosacea Safely - Health Reviews

Seattle, WA (PRWEB) March 16, 2013 Live Rosacea Free is the new treatment for rosacea made by Robert Campbell, who claims to help people treat rosacea naturally and permanently. As users get the...

Isotretinoin associated with eye infection risk

Teens whose acne is treated with isotretinoin may face twice the risk of eye infections, including conjunctivitis and styes, researchers say.

Well-known actress raises rosacea awareness

Actress Cynthia Nixon, best known for her role as Miranda Hobbes in the hit series “Sex and the City,” spoke to dermatologists about her experience with rosacea as part of the...

Health Tip: If You Have Rosacea

-- If you have the skin condition rosacea, you should avoid harsh cleansers that may worsen symptoms, the National Rosacea Society says. Here are the society's skin-cleansing recommendations: Wash wi...

Rosacea May Be Caused By Bacteria Released By Tiny Mites Living On The Skin

Scientists are closer to establishing a definitive bacterial cause for the skin condition rosacea. This will allow more targeted, effective treatments to be developed for sufferers, according to a rev...

FDA Approves Cip-Isotretinoin for Acne

Cipher Pharmaceuticals' novel, patented brand formulation of the acne medication isotretinoin will reach the US market later this year under the brand name Absorica, the company says. Medscape Medic...

Could Bacteria in Skin Mites Help Cause Rosacea?

By Amanda Gardner HealthDay Reporter THURSDAY, Aug. 30 (HealthDay News) -- Bacteria carried by tiny mites on the skin might be responsible for the common dermatological condition known...

Rosacea May Have a Bacterial Cause

Demodex folliculorum mites and their associated bacteria may have a role in the pathogenesis of rosacea. Medscape Medical News

Matching PubMed Articles

Rosacea Treatment with Intermediate-dose Isotretinoin: Follow-up with Erythema and Sebum Measurements.

Isotretinoin is one of the therapeutic options for rosacea. However, the response of erythema to treatment with isotretinoin is usually slow and incomplete with common (0.5-1 mg/kg/day) or low (10 mg/...

Rosacea : Systemic therapy with retinoids.

Systemic isotretinoin has been known for decades as an effective and safe therapeutic option in the treatment of severe and refractory forms of rosacea. It can also be used in special treatment-resist...

Rosacea: pathogenesis, clinical forms and therapy.

Rosacea is one of the most common chronic dermatological diseases. It is characterized by transient or persistent facial erythema, teleangiectasias, papules and pustules, usually on the central portio...

Rosacea and its ocular manifestations.

Rosacea is a chronic condition affecting the facial and ocular surface tissues. It is historically underdiagnosed and affects people of all ethnicities. The exact pathophysiology of rosacea is poorly...

Diagnosis and treatment of rosacea: state of the art.

Rosacea is a common disorder that is both under recognized and undertreated. Prevalence figures indicate that it may be present in 1 of every 10 adults in a primary care waiting room. Untreated, patie...

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement